Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Taki who wrote (132111)	4/30/2004 11:41:44 AM
From: Taki	Read Replies (1) \| Respond to of 150070

DNAP.041nice news.(COMTEX) B: DNAPrint Upgrades DNAWitness For Use in the War on Terror ( PR ewswire-FirstCall ) B: DNAPrint Upgrades DNAWitness For Use in the War on Terror ( PRNewswire-FirstC ll ) SARASOTA, Fla., Apr 30, 2004 /PRNewswire-FirstCall via COMTEX/ -- DNAPrint genomics (OTC Bulletin Board: DNAP) of Sarasota, FL announces that the forensics version of its innovative whole-genome test for individual ancestry admixture (DNAWITNESS 2.0) has been upgraded for enhanced utility in the international war on terrorism. The original DNAWitness(TM) 2.0 test was capable of reporting the percentage of "European," "western sub-Saharan African," "East Asian" and "Native American" admixture from a crime scene sample, where the colloquial terms in quotes represent ancestry traced to four of the major phlyogeographic clades that constitute the human family tree. The upgraded version of the test, DNAWitness(TM) 2.5 is capable of doing the same, but in addition can determine whether a donor of primarily European admixture is of continental European, Middle Eastern or Indo-Pakistani origin, or whether an East Asian's major ethnic affiliation is Northern (Chinese/Japanese), Central Asian or South East Asian. In its ability to effectively resolve between continental European, Middle Eastern and Indo-Pakistani origin for a crime scene sample, the upgraded DNAWitness(TM) 2.5 has unprecedented utility for use in the international war on terrorism. The DNAWitness(TM) 2.5 genome test is designed to allow forensics investigators to employ objective science, empiricism and statistical analysis in the reconstruction of a physical profile or fuzzy photo from DNA left at a crime scene. DNAPrint has filed both domestic and international PCT patent applications on many of the most useful markers, database systems and software algorithms necessary for this purpose. The new technology added to DNAWitness(TM) makes the product the first scientific instrument ever capable of measuring within-continent (i.e. ethnic) ancestry by reading across the entire genome. Prior to the development of DNAWitness(TM) 2.5, a small number of academic researchers were capable of making inferences on ethnicity from Y and mtDNA haplogroups, but these sequences reflect merely 2 of the 23 chapters (chromosomes) in every persons genome and from those short chapters, it is currently not possible to determine whether the ethnic affiliation of an individual human being is dominant or minor. Similarly, using CODIS STR (Short Tandem Repeat) loci, typically used for Forensic identity testing for the inference of ethnicity is notoriously not reliable and potentially misleading, since these genetic markers are not Ancestry Informative, and in fact are the opposite of Ancestry Informative, having been selected from the genome based on their lack of inter-population diversity. DNAWitness 2.5 has eliminated the confusion and is very accurate in predicting the genetic heritage of a donor's DNA. About DNAPrint genomics, Inc. DNAPrint genomics Inc. uses proprietary human genome research methods to develop genomic-based services and products. The Company introduced ANCESTRYbyDNA(TM) in the consumer market and DNAWitness(TM) in the forensic market in 2003. DNAPrint is developing products in the pharmacogenomic market and has a disease gene discovery program. The Company is traded on the Nasdaq OTC Bulletin Board under the ticker symbol: DNAP. For more information about the company, please visit www.dnaprint.com. All statements in this press release that are not historical are forward- looking statements within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. Media and Press Contacts Richard Gabriel DNAPrint genomics, Inc. CEO/President +1-941-366-3400 SOURCE DNAPrint genomics, Inc. CONTACT: Richard Gabriel, CEO/President of DNAPrint Genomics, Inc., +1 941-366-3400 URL: dnaprint.com prnewswire.com Copyright (C) 2004 PR Newswire. All rights reserved.

To: Taki who wrote (132111)	4/30/2004 12:07:31 PM
From: Taki	Respond to of 150070

SFXC.065.I am keeping an eye on it.It has run from .059 February 2004 to now 4 times.Three times to .11, and once to .16.It's an SSP find,that has gotten my attention. Has been a good trading stock for several people. I will be watching it like a hawk.I will be a huge buyer if it should go below .06. The main industries we are moving into is retail, home improvement, hardware, construction, maintenance, renovation, design and remodeling. We are aggressively pursuing the sale of our products in several home improvement and hardware store chains. We are currently in the process of negotiating several store implementations with two large home improvement and hardware chains. The industry outlook projections for 2004 are strong in home remodeling, one in particular reporting strong paint sales, which complements our primer coatings and complimentary products. We believe home sales, remodeling, and redesign will be strong indicators for our sales in the hardware stores. The National Association of Home Builders reported that there were more than 1 million new homes for 2003, with December reaching almost 100,000 alone. The fourth quarter of 2003 showed strong sales leading into 2004. In addition HUD is currently announcing new finance programs for home builders and President Bush's statements in the state of the union address both indicate that new housing and remodeling will be strong for 2004. Our short-term risk, over the next 12 months, will be the introduction of our product into the marketplace. Most chain stores purchase initial "test" quantities for several of their stores. If the merchandise turn over rate is successful, they will order larger quantities in more locations, until gradually all their locations are carrying a given product. Our plan of operation for the next 12 months will be to place products in test quantities in at least 15 large home improvement and hardware stores, and to have our test products accepted for larger orders by at least two (2) large chains. Once our products are introduced as test products, the initial sale of these products will be critical in determining the growth rate of our Company. Longer-term, our risk will be the ability to control the production and distribution of the product. We believe we are well positioned to build long-term relationships with our suppliers and protect our advantage through controlling either the product(s) or distribution of our product(s).